Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Improving hair health and managing conditions can enhance scalp cooling effectiveness in preventing hair loss during chemotherapy.

Most women undergoing chemotherapy experience hair loss, and many cope by using wigs or bonnets.

Provenge extends prostate cancer survival by about 4 months.

New therapies targeting skin neuroimmune interactions could treat neuropathic pain.

Oral minoxidil effectively improves hair regrowth in cancer survivors with late alopecia.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Preventing and managing skin issues from cancer treatment is crucial, especially in high UV areas like Australia and New Zealand.

Hair follicles could be used to noninvasively monitor our body's internal clock and help identify risks for related diseases.

The conclusion suggests that focusing on certain cellular pathways may improve the prevention and repair of hair loss caused by radiotherapy.

Stem cell technology may improve hair loss treatments by providing more effective and personalized options.

Consult an oncologist before using supplements for hair loss during breast cancer treatment.

Phenolic compounds may help treat hair loss, but more research is needed.

Chemotherapy worsens nutritional status in breast cancer patients, requiring targeted nutritional strategies.

Early detection and a multidisciplinary approach are crucial for improving gastric cancer survival rates.

Madarosis (eyebrow and eyelash loss) significantly affects quality of life for breast cancer patients on taxane-based chemotherapy.

Taxane chemotherapy can cause permanent hair loss by damaging hair follicles and altering their DNA.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Docetaxel chemotherapy causes more long-term hair loss and dissatisfaction than paclitaxel.

The treatment is safe and shows promise for metastatic breast cancer.

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

Scalp cooling therapy is costly and often not covered by insurance, limiting access for low-income patients.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

Taxane-based chemotherapy causes more hair loss and skin changes in Asian breast cancer patients.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

Tamoxifen increases the risk of lasting hair loss after chemotherapy despite scalp cooling.

Topical minoxidil may help regrow hair after permanent hair loss from chemotherapy.

The tool accurately tracks eyebrow hair loss in chemotherapy patients.